CDKN2A and Huntington disease: Remarkably, FOXO3 target reprogramming represses the transcription modulator and p16INK4a activator ETS2 (Irelan et al., 2009), which antagonizes p16INK4a expression and which may represent an adaptive response as p16INK4a promotes the senescence of human HD NSCs and MSNs.